Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Sponsor: Century Therapeutics, Inc.
Summary
This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.
Official title: A Long-Term Follow-up Study for Subjects Previously Treated With A Century Therapeutics Cellular Therapy Product
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
375
Start Date
2024-04-29
Completion Date
2040-03
Last Updated
2025-06-25
Healthy Volunteers
No
Interventions
No Intervention
As this is a non-interventional rollover, long-term safety follow-up study, no intervention will be administered.
Locations (7)
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Corewell Health
Grand Rapids, Michigan, United States
Levine Cancer Institute
Charlotte, North Carolina, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Swedish Cancer Institute
Seattle, Washington, United States